Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. SURGICAL ENDO STITCH LAUNCH SLATED FOR LATE THIRD QUARTER

This article was originally published in The Gray Sheet

Executive Summary

U.S. SURGICAL ENDO STITCH LAUNCH SLATED FOR LATE THIRD QUARTER or early fourth quarter, according to the firm. Cleared via 510(k) in late March, the internal suturing device "allows a surgeon to suture laparoscopically with the same speed and ease as an open surgery, thus opening many additional procedures to laparoscopy," USSC President and CEO Leon Hirsch told a May 10 session of the Alex. Brown investment conference in Baltimore.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel